Jane Street’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$66.1K Sell
18,300
-15,400
-46% -$53.3K ﹤0.01% 10859
2025
Q4
$115K Sell
33,700
-6,900
-17% -$33.5K ﹤0.01% 10112
2025
Q3
$276K Buy
40,600
+15,300
+60% +$126K ﹤0.01% 9072
2025
Q2
$345K Sell
25,300
-10,500
-29% -$99.2K ﹤0.01% 7606
2025
Q1
$195K Buy
35,800
+25,700
+254% +$146K ﹤0.01% 8472
2024
Q4
$50K Buy
10,100
+100
+1% +$524 ﹤0.01% 8969
2024
Q3
$52.4K Buy
+10,000
New +$57.7K ﹤0.01% 9172
2021
Q4
Sell
-32,400
Closed -$201K 10501
2021
Q3
$201K Sell
32,400
-202,900
-86% -$1.73M ﹤0.01% 8834
2021
Q2
$2.77M Buy
235,300
+70,500
+43% +$811K ﹤0.01% 3716
2021
Q1
$2.61M Buy
+164,800
New +$2.97M ﹤0.01% 3522

Other funds holding LFMD

Jane Street's LFMD Position: Q1 2026 in Review

Jane Street increased its LifeMD (LFMD) stake by 66% in Q1 2026, buying an estimated $504K and bringing the position to 366,673 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #5883.

Jane Street first reported a position in LFMD in Q1 2021 and has held it in 18 quarters since. The position peaked at $4.68M in Q2 2025. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.

  • Jane Street held 366,673 shares of LifeMD worth $1.32M as of Q1 2026.
  • Jane Street bought 145,575 LifeMD shares in Q1 2026, an estimated $504K.
  • LifeMD made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5883 holding.
  • Jane Street first reported a position in LifeMD in Q1 2021 and has held it in 18 quarters since.
  • Jane Street's LifeMD position peaked at $4.68M in Q2 2025.
  • 102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.